Chronic angle closure glaucoma: presentation and outcomes at a tertiary eye hospital of Saudi Arabia


  • Sultan A. Alzuhairy Department of Ophthalmology, College of Medicine, Qassim University, Qassim Burydah, Saudi Arabia



Chronic angle closure glaucoma, Glaucoma, Glaucoma surgery, Laser iridotomy, Vision impairment


Background: Detection and management of chronic angle closure glaucoma (CACG) differ from primary open angle glaucoma (POAG). For general ophthalmologists in institutions with limited resources, timely detection and standard management of primary angle closure glaucoma (PACG) remains challenging.

Methods: A retrospective chart review was performed of patients with CACG who presented to an eye unit in a hospital in central Saudi Arabia. Data were analyzed over a 5-year period regarding presentation, determinants and management outcomes of clinically diagnosed CACG cases.

Results: The study sample was comprised of 102 eyes of 53 CACG patients. Bilateral disease at presentation was diagnosed in 92.4% patients. Nearly half of these patients were hypertensive, and more than one-fourth had diabetes or ocular comorbidities. Eighty eyes (78.4%) had a history of ocular surgery. A closed anterior chamber angle was detected in all eyes. The mean intraocular pressure (IOP) was 18.1±6.0mmHg, with or without medications. IOP greater than 22mmHg was detected in 26 (25.5%) eyes. The median cup-to-disk (CD) ratio was 0.6 [intraquartile range (IQR), 0.4; 0.7]. Laser peripheral iridotomy (PI) was performed in 61 eyes, trabeculectomy in 7 eyes, cataract extraction in 1 eye and combinations glaucoma surgeries in 7 eyes. Ninety-eight eyes had best-corrected visual acuity ≥20/200. The number of glaucoma medications declined significantly following surgery (χ2=32, P< 0.001).

Conclusions: Laser PI was the main management modality for CACG in the study area. Goal of preventing blindness in eyes with CACG seems to be achieved.


Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183-93.

Marchini G, Chemello F, Berzaghi D, Zampieri A. New findings in the diagnosis and treatment of primary angle-closure glaucoma. Prog Brain Res. 2015;221:191-212.

Sihota R. Classification of primary angle closure disease. Curr Opin Ophthalmol. 2011;22(2):87-95.

Emanuel ME, Parrish RK 2nd, Gedde SJ. Evidence-based management of primary angle closure glaucoma. Curr Opin Ophthalmol. 2014;25(2):89-92.

Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. 2009;54(2):211-25.

Lou H, Zong Y, Ge YR, Cheng JW, Wei RL. Efficacy and tolerability of latanoprost compared with timolol in the treatment of patients with chronic angle-closure glaucoma. Cur Med Res Opin. 2014 Jul 1;30(7):1367-73.

Al Rashed AS, Al Subaie HA, Al Hathloul HS, Al Shehab KA, Al Naim MA, Kaliyadan KF, Aet al. Types of glaucoma in a university health centre in Al‑Ahsa, Saudi Arabia: a pilot study. Nigerian J Ophthalmol. 2015;23(1):12-5.

Alzuhairy S, Alalola FS, AlAkeel HA, Alayed DM, Al-Harbi IM, Al-Shetwi MM, et al. Profile and management outcomes of glaucoma cases at Qassim University Hospital. Int J Health Sci. 2018 Sep;12(5):20.

World Health Organization‎. International statistical classification of diseases and related health problems, 10th revision, 5th Ed,; 2016. World Health Organization. Available at:

Wang B, Sakata LM, Friedman DS, Chan YH, He M, Lavanya R, et al. Quantitative iris parameters and association with narrow angles. Ophthalmol. 2010 Jan 1;117(1):11-7.

Schindelin J, Rueden CT, Hiner MC, Eliceiri KW. The Image J ecosystem: an open platform for biomedical image analysis. Molecular Reprod Develop. 2015 Jul;82(7-8):518-29.

Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version. Available at: Accessed 11 November 2018.

Day AC, Baio G, Gazzard G, Bunce C, Azuara-Blanco A, Munoz B, et al. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol. 2012 Jan 1:bjophthalmol-2011.

Wright C, Tawfik MA, Waisbourd M, Katz LJ. Primary angle‐closure glaucoma: an update. Acta Ophthalmologica. 2016 May;94(3):217-25.

He M, Foster PJ, Johnson GJ, Khaw PT. Angle-closure glaucoma in East Asian and European people. Different diseases? Eye (Lond). 2006;20(1):3-12.

Zhou M, Wang W, Huang W, Zhang X. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS One. 2014;9(8):e102972.

Havens SJ, Gulati V. Neovascular glaucoma. In Retinal Pharmacotherapeutics. Karger Publishers. 2016;55:196-204.

Robert AA, Al Dawish MA, Braham R, Musallam MA, Al Hayek AA, Al Kahtany NH. Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions. Curr Diabetes Rev. 2017;13(1):59-64.

Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL, et al. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011;9:76.

Waisbourd M, Pruzan NL, Johnson D, Ugorets A, Crews JE, Saaddine JB, et al. The Philadelphia glaucoma detection and treatment project: detection rates and initial management. Ophthalmol. 2016 Aug 1;123(8):1667-74.

Prum BE, Herndon LW, Moroi SE, Mansberger SL, Stein JD, Lim MC, et al. Primary angle closure preferred practice pattern® guidelines. Ophthalmol. 2016 Jan 1;123(1):P1-40.

See JL, Aquino MC, Aduan J, Chew PT. Management of angle closure glaucoma. Indian J Ophthalmol. 2011;59(Suppl1):S82.

Le JT, Rouse B, Gazzard G. Iridotomy to slow progression of visual field loss in angle-closure glaucoma. Cochrane Database Syst Rev. 2018 Jun 13;6:CD012270.

de Silva DJ, Gazzard G, Foster P. Laser iridotomy in dark irides. Br J Ophthalmol. 2007;91(2):222-5.

Hashemi H, KhabazKhoob M, Yekta A, Mohammad K, Fotouhi A. Distribution of iris colors and its association with ocular disorder in the Tehran eye study. Iranian J Ophthalmol. 2010 Jan 1;22(1):7-14.

Vijaya L, Asokan R, Panday M, George R. Is prophylactic laser peripheral iridotomy for primary angle closure suspects a risk factor for cataract progression? The Chennai Eye Disease Incidence Study. Br J Ophthalmol. 2017 May 1;101(5):665-70.

Trikha S, Perera SA, Husain R, Aung T. The role of lens extraction in the current management of primary angle-closure glaucoma. Curr Opin Ophthalmol. 2015 Mar 1;26(2):128-34.






Original Research Articles